Kathleen P. Gallagher Avidity Biosciences, Inc. (RNA) insider trading activity

RNA Quotes by TradingView

Kathleen P. Gallagher is Chief Program Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 50,554 shares of RNA, which is worth approximately $1.57 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 5,875 shares (Common Stock) at a price of $32.16 per share, resulting in proceeds of $188,939. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.6K
n/a 3M change
n/a 12M change
Total Value Held $1.57 Million

Kathleen P. Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$188,939 $32.16 p/Share
5,875 Reduced 10.41%
50,554 Common Stock
Feb 03 2025
BUY
Exercise of conversion of derivative security
$97,818 $16.65 p/Share
5,875 Added 9.43%
56,429 Common Stock
Jan 22 2025
SELL
Open market or private sale
$169,770 $30.16 p/Share
5,629 Reduced 10.02%
50,554 Common Stock
Jan 21 2025
SELL
Open market or private sale
$108,127 $28.59 p/Share
3,782 Reduced 6.31%
56,183 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 29.42%
59,965 Common Stock
KPG

Kathleen P. Gallagher

Chief Program Officer
San Diego, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA